KF
CORV

Krilogy Financial’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Krilogy Financial’s Portfolio CORV Stock Details CORV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-9
Closed – – 781
2018
Q3 		$0 Buy
+9
New +$40 ﹤0.01% 848
2018
Q2 		– Sell
-19
Closed – – 707
2018
Q1 		$0 Hold
19
– – ﹤0.01% 830
2017
Q4 		$0 Sell
19
-8
-30% -$13 ﹤0.01% 864
2017
Q3 		$0 Sell
27
-9
-25% -$31 ﹤0.01% 864
2017
Q2 		$0 Sell
36
-24
-40% -$87 ﹤0.01% 799
2017
Q1 		$0 Hold
60
– – ﹤0.01% 730
2016
Q4 		$0 Hold
60
– – ﹤0.01% 780
2016
Q3 		$0 Hold
60
– – ﹤0.01% 793
2016
Q2 		$0 Hold
60
– – ﹤0.01% 774
2016
Q1 		$1K Hold
60
– – ﹤0.01% 669
2015
Q4 		$0 Hold
60
– – ﹤0.01% 627
2015
Q3 		$1K Buy
+60
New +$553 ﹤0.01% 601

Other funds holding CORV

Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.23B AUM 51.32% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Krilogy Financial's CORV Position: Q4 2018 in Review

Krilogy Financial sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q4 2018, closing a stake of 9 shares.

Krilogy Financial first reported a position in CORV in Q3 2015 and held it in 12 quarters. The position peaked at $1K in Q1 2016. 36 funds tracked by Wall St. Rank hold CORV as of Q4 2018.

  • Krilogy Financial reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q4 2018 after selling out during the quarter.
  • Krilogy Financial sold 9 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q4 2018.
  • Krilogy Financial first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q3 2015 and held it in 12 quarters.
  • Krilogy Financial's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $1K in Q1 2016.
  • 36 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q4 2018.

Based on Krilogy Financial's 13F filing for Q4 2018, filed 14 Feb 2019.